Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects
Clinical trial NCT01764386 · COMPLETED
Trial details
- NCT number
- NCT01764386
- Sponsor
- Orexigen Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2014-09-01
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.